Treating Dog Cataracts with Can-C™ N-acetylcarnosine Eye Drops.

The discovery of N-acetylcarnosine, in the form of Can-C™ eye drops for the treatment and reversal of canine cataract has provided a safe and effective alternative to costly and risky eye surgery. Proven in clinical trials and in use now for over 10 years by pet owners and veterinarians around the globe, Can-C has proven itself to be the optimal treatment for dogs suffering from debilitating cataracts.

N-acetylcarnosine is a special ocular form of the peptide, L-carnosine a natural antioxidant that can reverse and prevent the effects of age-related disorders like cataract. Canine cataract can cause varying degrees of disability in dogs which can vary from slightly blurry vision to a complete loss of vision or blindness. In canines, cataracts are often hereditary and gradual in their development, blocking more and more vision as the animal matures into old age.

Under the supervision of Innovative Vision Products founder, Dr. Mark Babizhayev MA PhD, clinical studies were performed on rabbits, dogs and ultimately on humans to test the efficacy and safety of Can-C N-acetylcarnosine eye drops. The study produced remarkable results with no negative side effects noted and the beneficial affects proved to be sustainable. The trials resulted in an astounding 96% improvement of affected canine eyes. Improved visual behaviour of the participants was noted within a few weeks of treatment. Dogs with either immature or ripe cataracts showed significant decrease of cataract symptoms. Reversal of the disease condition started from the periphery of the affected lens with increased transparency of the entire lens over the period of the trial. Interestingly it was noted that canine cataracts actually responded earlier to the treatment then their human counterparts.

Can-C™ N-acetylcarnosine eye drop solution is an excellent and safe alternative in cases especially where surgery is not a viable option. Efficacy has been proven from the smallest to the largest of canine breeds. Improvement of the condition presents as a gradual shrinking of the cataract accompanied by the dog’s improved behaviour, confidence and mood. Initial signs of improvement often present within the first 2-3 months. Optimal results are generally achieved over 6-12 months time.

The daily dosage used in treating dog cataract is a little less then that recommended for humans at 3 drops daily to each affected eye. Over time and once optimal results have been achieved; the dose should be reduced to 1 drop a day for maintenance purposes.
Depending on the severity of the dogs’ cataract, reversal leading to improved vision is usually achieved. In the case of steroid medication or diabetic induced cataract, complete healing can take longer. Additionally, if the cataract is advanced to the point of total blindness, results are generally less significant. In these cases the daily application of Can-C™ can help to alleviate cataract associated irritations, reduce infection risks and stabilize the condition.

Can-C is a soothing antioxidant solution which improves the ph balance of the eye and so causes no discomfort to the animal. The product has been sold for over a decade with no reports of negative side effects in either humans or animals. Instead, it’s a product fully recommended to improve the overall health of your dog’s eyes. Once optimal results have been achieved its recommended the product is used at low dosage to prevent the return of cataract.

This article is free to republish provided the authors resource box remains intact.

Diane Brooks has vast knowledge and experience with Can-C™ N-Acetylcarnosine - N-Acetyl-Carnosine eye drops and the effects on cataracts.